生分解性医療用プラスチックの世界市場2019-2023

Technavioが発行した調査報告書(IRTNTR31447)
◆英語タイトル:Global Biodegradable Medical Plastics Market 2019-2023
◆商品コード:IRTNTR31447
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年6月19日
◆ページ数:120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、米州、アジア太平洋、EMEA(ヨーロッパ・中東・アフリカ)
◆産業分野:材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、生分解性医療用プラスチックの世界市場について調べ、生分解性医療用プラスチックの市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、生分解性医療用プラスチックの市場規模をセグメンテーション別(用途別(医療機器、医療パッケージ、その他))と地域別(グローバル、米州、アジア太平洋、EMEA(ヨーロッパ・中東・アフリカ))に分けて算出しました。
・サマリー
・レポートの範囲
・生分解性医療用プラスチックの市場状況
・生分解性医療用プラスチックの市場規模
・生分解性医療用プラスチックの市場予測
・生分解性医療用プラスチックの世界環境:ファイブフォース分析
・市場セグメンテーション:用途別(医療機器、医療パッケージ、その他)
・生分解性医療用プラスチックの顧客状況
・主要地域別市場規模:グローバル、米州、アジア太平洋、EMEA(ヨーロッパ・中東・アフリカ)
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...
【レポートの概要】

About this market

The waste generated by hospitals mostly contains medical plastics that usually end up in landfills. This could be better managed if hospitals shift their focus toward the use of biodegradable disposable products. Deepening focus on the environmental risk factors associated with the use of plastic is resulting in the elimination of plastic use across various industries, including healthcare. The UK government recently announced its plans to eliminate the use of all kinds of avoidable plastic by 2042. Enterprises are working towards developing the replacement of plastics that is sustainable and is easily degradable such as biodegradable plastics. The growing preference for sustainable products is expected to drive the growth of the global biodegradable medical plastics market size at a CAGR of more than 11% during 2019-2023.

Market Overview

Growth in geriatric population

The geriatric population is more prone to several diseases and postural control problems. The high prevalence of orthopedic disorders among the elderly population has increased the demand for medical products such as medical implants, medical devices, and others. This is expected to have a positive impact on the growth of the global biodegradable medical plastics market size.

High manufacturing cost

Compared to conventional medical plastics, the cost of manufacturing biodegradable medical plastics is high. Factors like the limited availability of bio-based renewable feedstock and higher research and development costs increase the production costs of biodegradable medical plastics. This increasing production costs will have an inflationary impact on the prices of biodegradable medical plastics.

For the detailed list of factors that will drive and challenge the growth of the biodegradable medical plastics market size during 2019-2023, view our report.

Competitive Landscape

The market appears to be fragmented with several players occupying the market share. Companies such as Arkema Group and BASF SE have intensified competition. Factors such as the increasing preference for sustainable products and the growth of the geriatric population will provide significant growth opportunities for biodegradable medical plastics manufacturers. Arkema Group, BASF SE, Corbion NV, Evonik Industries AG, and Koninklijke DSM NV are some of the major companies covered in this report.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

Market segmentation by application

Comparison by application

Medical devices – Market size and forecast 2018-2023

Medical packaging – Market size and forecast 2018-2023

Others – Market size and forecast 2018-2023

Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

APAC – Market size and forecast 2018-2023

MEA – Market size and forecast 2018-2023

South America – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 11: MARKET TRENDS

Adoption of innovative raw materials

Emerging applications of biodegradable medical plastics

Rise in use of biodegradable composite materials for implants

PART 12: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 13: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Arkema Group

BASF SE

Corbion NV

Evonik Industries AG

Koninklijke DSM NV

PART 14: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

Exhibit 01: Global biomaterials market

Exhibit 02: Segments of global biomaterials market

Exhibit 03: Market characteristics

Exhibit 04: Market segments

Exhibit 05: Market definition – Inclusions and exclusions checklist

Exhibit 06: Market size 2018

Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 09: Five forces analysis 2018

Exhibit 10: Five forces analysis 2023

Exhibit 11: Bargaining power of buyers

Exhibit 12: Bargaining power of suppliers

Exhibit 13: Threat of new entrants

Exhibit 14: Threat of substitutes

Exhibit 15: Threat of rivalry

Exhibit 16: Market condition – Five forces 2018

Exhibit 17: Application – Market share 2018-2023 (%)

Exhibit 18: Comparison by application

Exhibit 19: Medical devices – Market size and forecast 2018-2023 ($ millions)

Exhibit 20: Medical devices – Year-over-year growth 2019-2023 (%)

Exhibit 21: Medical packaging – Market size and forecast 2018-2023 ($ millions)

Exhibit 22: Medical packaging – Year-over-year growth 2019-2023 (%)

Exhibit 23: Others – Market size and forecast 2018-2023 ($ millions)

Exhibit 24: Others – Year-over-year growth 2019-2023 (%)

Exhibit 25: Market opportunity by application

Exhibit 26: Customer landscape

Exhibit 27: Market share by geography 2018-2023 (%)

Exhibit 28: Geographic comparison

Exhibit 29: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 30: North America – Year-over-year growth 2019-2023 (%)

Exhibit 31: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 32: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 33: APAC – Market size and forecast 2018-2023 ($ millions)

Exhibit 34: APAC – Year-over-year growth 2019-2023 (%)

Exhibit 35: MEA – Market size and forecast 2018-2023 ($ millions)

Exhibit 36: MEA – Year-over-year growth 2019-2023 (%)

Exhibit 37: South America – Market size and forecast 2018-2023 ($ millions)

Exhibit 38: South America – Year-over-year growth 2019-2023 (%)

Exhibit 39: Key leading countries

Exhibit 40: Market opportunity

Exhibit 41: Impact of drivers and challenges

Exhibit 42: Vendor landscape

Exhibit 43: Landscape disruption

Exhibit 44: Vendors covered

Exhibit 45: Vendor classification

Exhibit 46: Market positioning of vendors

Exhibit 47: Arkema Group – Vendor overview

Exhibit 48: Arkema Group – Business segments

Exhibit 49: Arkema Group – Organizational developments

Exhibit 50: Arkema Group – Geographic focus

Exhibit 51: Arkema Group – Segment focus

Exhibit 52: Arkema Group – Key offerings

Exhibit 53: BASF SE – Vendor overview

Exhibit 54: BASF SE – Business segments

Exhibit 55: BASF SE – Organizational developments

Exhibit 56: BASF SE – Geographic focus

Exhibit 57: BASF SE – Segment focus

Exhibit 58: BASF SE – Key offerings

Exhibit 59: Corbion NV – Vendor overview

Exhibit 60: Corbion NV – Business segments

Exhibit 61: Corbion NV – Organizational developments

Exhibit 62: Corbion NV – Geographic focus

Exhibit 63: Corbion NV – Segment focus

Exhibit 64: Corbion NV – Key offerings

Exhibit 65: Evonik Industries AG – Vendor overview

Exhibit 66: Evonik Industries AG – Business segments

Exhibit 67: Evonik Industries AG – Organizational developments

Exhibit 68: Evonik Industries AG – Geographic focus

Exhibit 69: Evonik Industries AG – Segment focus

Exhibit 70: Evonik Industries AG – Key offerings

Exhibit 71: Koninklijke DSM NV – Vendor overview

Exhibit 72: Koninklijke DSM NV – Business segments

Exhibit 73: Koninklijke DSM NV – Organizational developments

Exhibit 74: Koninklijke DSM NV – Geographic focus

Exhibit 75: Koninklijke DSM NV – Segment focus

Exhibit 76: Koninklijke DSM NV – Key offerings

Exhibit 77: Validation techniques employed for market sizing

Exhibit 78: Definition of market positioning of vendors



【掲載企業】

Arkema Group、BASF SE、Corbion NV、Evonik Industries AG、Koninklijke DSM NV

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 生分解性医療用プラスチックの世界市場2019-2023(Global Biodegradable Medical Plastics Market 2019-2023)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆